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the prevalent screen, but expected figures for incident screens can also be calculated by applying different parameters from the Swedish two county study.
The expected invasive cancer detection rate and age The expected cancer detection rate at a prevalent screen is based on the prevalence/ incidence ratio from the Swedish two county study and the estimated background incidence for England and Wales, both of which increase with age. Table 1 shows the prevalence/ incidence ratio for invasive cancers (in situ cancers have been excluded) seen in different age groups in the Swedish two county study (Duffy S, personal communication).
As can be seen this ratio increased with age. The prevalence to incidence ratio will be approximately equal to the sensitivity of screening multiplied by the mean sojourn time.' The sojourn time is the length oftime a preclinical lesion is detectable by screening. 
Age group
The rapid rise of the prevalence/incidence ratio with age may be partly explained by the longer time that preclinical lesions are detectable in older women, younger women tending to have faster growing tumours with a shorter average sojourn time." The increase may also reflect a lower sensitivity of mammography in younger women.'
The background incidence for England and Wales has been calculated from recently collected breast cancer incidence data (Woodman C, personal communication), showing incidence rates for women from 1980 to 1987 (that is, before the national screening programme had begun) for women aged 50-64. The rates show an increase with time, and linear and log-linear modelling have been used to extrapolate rates to the years after the introduction of screening, This is necessary because screening itself will cause an increase in incidence rates. Because of the uncertainty in knowing whether the rates would have continued to rise, the midpoint of the 1987 rates and Abstract Close monitoelng of data from individual prograrnmes is required to evaluate the potential of the breast screening programme to reach the Health a/the Nation target of 25% reduction in breast cancer mortality in the invited age group by the year 2000. This paper outlines the use of indirect age standardisation techniques to compare the performance of individual programmes in terms of their invasive cancer detection rates. Expected invasive cancer detection rates are calculated by applying data from the Swedish two county study to estimated England and Wales background incidence rates for different age strata. If the national programme overall meets these targets then the required mortality reduction should be achieved. The sallie method can be used by other (national) screening programmes by applying the relevant background incidence figures to produce internationally comparable data. (Journal of Medical Screening 1996; 3:79-81) Key words: breast cancer; monitoring; age standardisation.
The National Health Service breast screening programme aims at achieving a 25% reduction in breast cancer mortality in the population invited for screening by the year 2000. 1 Performance targets for a number of criteria for the 88 screening programmes in the United Kingdom were set at the start of the programme and revised in 1993. 2 These criteria include the cancer detection rate at prevalent and incident screens, the detection rate of invasive cancers~10 mm in diameter, and interval cancer rates. Targets for cancer detection rates have been set by using data from the Swedish two county randomised controlled trial' (referred to later in the text as the Swedish two counties study), and applying these to national (England and Wales) incidence figures. It is considered that if the United Kingdom programmes on average reach these targets then the National Health Service breast screening programme is likely to achieve the target reduction in mortality. This paper discusses the need to allow for different age distributions and numbers of women screened by each programme when using these targets to monitor the performance of individual breast screening programmes. The paper will focus on the invasive cancer detection rate at the screening year has been used. Table 2 illustrates incidence rate data for selected ages extrapolated to the year 1995. An approximate estimate of the prevalence to incidence ratio at a given age has been calculated by modelling the log of the prevalence to incidence ratio with the midpoint age of the three age groups shown in table 1. The expected cancer detection rate for the National Health Service breast screening programme at any age was calculated by multiplying this prevalence/incidence ratio by the estimated background incidence at that age. It should be noted that the expected rates will increase marginally with screening year because of the increase in the estimated background incidence with increasing screening year. Table 3 shows the expected invasive cancer detection rates per 1000 for ages 50-64 inclusive, for women screened in the prevalent round of the screening year 1 April 1994 to 31 March 1995. 3 5
Standardised detection ratio
The standardised detection ratio (SDR) is defined as the observed number of screen detected invasive cancers divided by the expected number of screen detected invasive cancers. The expected numbers have been calculated by applying the expected rate for each age strata to the number of women screened in that strata, to produce the age specific expected numbers of invasive cancers.
SDR=ĩ s.Ri
where I is the number of invasive cancers, S, is the number of women screened, and R; is the expected rate, for each ith age strata.
In practice the calculations have used data from screening programme returns (KC62 forms), which include information in five-year age groups. For women aged 50-64 these age groups are 50-54, 55-59, and 60-64. Women in each of these age groups have been assumed to be at the midpoint age -that is, 52.5, 57.5, and 62.5. These approximations will be most accurate for the earlier prevalent round "* Provisional rates.
Observed invasive cancers in women aged 50-64 = 92. Standardised detection ratio= 92/108.24 = 0.85. screens, when all women aged 50-64 were being invited for their first screen in the National Health Service breast screening programme. As the programme progresses more women having prevalent screens will be aged 50, 51, or 52, and very few women should be screened for the first time in the older two age bands. The appropriate estimated age for women aged 50-54 for programmes that have completed the prevalent round is therefore 51.5. Table 4 shows an example of the SDR calculations for a hypothetical screening programme. The total number of observed invasive cancers between ages 50 and 64 is 92, and the calculated expected number of invasive cancers is 108.24, giving an SDR of 0.85. Confidence intervals can then be calculated for the SDR (table 5) and the performance of the screening programme compared with that expected from the Swedish two county study performance. An SDR of 1 would indicate the observed number of invasive cancers was the same as that expected, greater than 1 would indicate higher, and less than 1 lower than the two county experience.
Advantages of the SDR over other methods of allowing for age
In practice, a number of different methods can be used to allow for different age distributions in screening programmes. The advantages of the SDR over other methods, such as direct standardisation or the inspection of age specific rates, are the usual advantages of indirect standardisation -namely, that it is not affected by small numbers in individual categories and it does not require knowledge of rates in individual age groups, which are not always available (for example, on KC62 returns). An additional advantage is that the statistical properties of the SDR are particularly simple being based on the Poisson distribution for the total expected numbers.
Extension of the standardised detection ratio
This paper concentrates on the use of the SDR for assessing the results obtained at the prevalence screen. The extension to screening activities that include a mixture of prevalence and incidence screens, as will apply to all programmes in the United Kingdom in the future, is immediate. However, the expected detection rates for women screened in the incident round are subject to a number of complications. Firstly, the detection rate at the incident screen for each programme will be partly dependent on the prevalent screen and the number of cancers detected by early recall. Secondly, not all screening programmes use a three year screening period -for example, programmes that have opted for a two year screening period and programmes that are part of trials such as the "frequency trial". Targets have been set for detection rates at incident screens, but further work is required to allow for such variations.
Discussion
The SDR has been developed as a useful statistical tool in determining the performance of individual screening programmes as well as the programme as a whole. The advantage of the SDR is that it incorporates both age standardisation and also target values by its explicit reference to screening results from the Swedish two county study. It should be noted that although the Swedish two county study showed a 34% mortality reduction in the study group compared with the control group, the 95% confidence interval of 16% to 48%3 indicates that there is uncertainty in the estimated mortality reduction from the National Health Service breast screening programme even if the targets are achieved.
An important consequence of using calculated estimates as targets is that the "target" is not strictly a target in the sense of a goal aimed at, but is an "expected" figure. Therefore, we would not expect more than 50% of programmes to reach the "target" unless programmes were performing on average better than the Swedish two county study expectation.
It is clear that the SDR depends on the accuracy of the expected rates. A major problem with the expected rate calculations is that of knowing the underlying incidence rate in England and Wales in the absence of screening. The updated incidence rates from 1980-87 that have been reported (Woodman C, personal communiation) show an increase in background incidence rate between these years. It is of course not possible to know exactly the background incidence rate now that screening has started in all regions, and women attending for screening may have a different underlying incidence than the total population. A number of different modelling techniques produce marginally different estimates and further work is required to clarify some of the problems encountered. One difficulty is that the rates do not rise equally in all three age bands. In particular, the increase in the rate for the 55-59 year age band is very small, perhaps because of a cohort effect. In the context of this paper the midpoint estimate is considered an 81 adequate approximation to minimise any inherent error in the estimation until further work is undertaken. The SDR as described does not allow for geographical differences in breast cancer rates. A number of difficulties are apparent in producing correction factors for background incidence. Firstly, the completeness of cancer registration in individual regions needs to be considered, and secondly, the variation within a region may be such that using regional incidence rates would be inappropriate at the level of an individual screening programme. These issues will be considered in a further paper.
A second potential source of error relates to the Swedish two county prevalence/incidence ratio figures. These will be subject to sampling error because of the limited size of the randomised controlled trial, although because both the prevalence and incidence screens had over 400 screen detected cancers this potential error may be small. Given these caveats the expected rates may be subject to an error of the order of plus or minus 10%, in addition to any error related to the background incidence in the catchment area of the screening programme. As a measure of programme performance these errors compare favourably with those associated with the use of the crude invasive cancer detection rate for women aged 50-64, which because of the differing age distributions of women screened by individual programmes can be a highly misleading statistic.
In summary, the SDR using indirect standardisation is the preferred method of assessing the invasive cancer detection rates of individual screening programmes for two main reasons: firstly, the SDR can be calculated from the KC62 returns; and secondly, it provides a direct comparison of the observed number of invasive cancers and the expected number from Swedish two county study data. It therefore provides an estimate of the ability of screening programmes to achieve the cancer detection rates necessary to reach the Health of the Nation target.
